HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rapid increase in contact allergy to Kathon CG in Finland.

Abstract
In unselected eczema patients subjected to routine patch testing, the number with positive reactions to Kathon CG 100 ppm increased from none in 1983 to 0.7% in January-August 1985, and to 4.6% in September 1985 to March 1986. Repeated open application tests (ROAT) with creams containing 7-15 ppm of the isothiazolinones were positive in 12 of 24 patients tested. 2 of the ROAT-positive cases had negative patch tests to 100 ppm Kathon CG, but 1 was positive with 200 ppm. Atopic dermatitis, chronic hand dermatitis and lower leg dermatitis were the most common disorders in the positive patients. The cause of the rapid increase of Kathon CG allergy in Finland during the winter of 1985-1986 was the use of a popular moisturizing cream containing first 19 ppm, then 7 ppm of a mixture of 2 isothiazolinones (Euxyl K 100).
AuthorsM Hannuksela
JournalContact dermatitis (Contact Dermatitis) Vol. 15 Issue 4 Pg. 211-4 (Oct 1986) ISSN: 0105-1873 [Print] England
PMID3802805 (Publication Type: Journal Article)
Chemical References
  • Cosmetics
  • Pharmaceutic Aids
  • Preservatives, Pharmaceutical
  • Thiazoles
  • Kathon 886
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Cosmetics (adverse effects)
  • Dermatitis, Contact (etiology)
  • Dose-Response Relationship, Drug
  • Facial Dermatoses (etiology)
  • Finland
  • Hand Dermatoses (etiology)
  • Humans
  • Middle Aged
  • Patch Tests
  • Pharmaceutic Aids (adverse effects)
  • Preservatives, Pharmaceutical (adverse effects)
  • Thiazoles (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: